JP2614474B2 - Whitening cosmetics - Google Patents
Whitening cosmeticsInfo
- Publication number
- JP2614474B2 JP2614474B2 JP63011585A JP1158588A JP2614474B2 JP 2614474 B2 JP2614474 B2 JP 2614474B2 JP 63011585 A JP63011585 A JP 63011585A JP 1158588 A JP1158588 A JP 1158588A JP 2614474 B2 JP2614474 B2 JP 2614474B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- derivatives
- pigmentation
- lightening
- salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Description
【発明の詳細な説明】 産業上の利用分野 本発明は、紫外線による皮膚の黒化あるいはシミ、ソ
バカスなどの皮膚の色素沈着を消失、淡色化もしくは予
防する美白化粧料に関する。Description: BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a whitening cosmetic which eliminates, pales or prevents skin blackening due to ultraviolet rays or skin pigmentation such as spots and freckles.
従来の技術および課題 従来、美白化粧料組成物としてはビタミンCおよびそ
の誘導体、あるいは還元剤、胎盤エキスなどのチロジナ
ーゼ活性阻害剤を配合したものが知られている。しかし
ながら、これら従来の美白化粧料は培養細胞による in
vitroの実験ではメラニン産性抑制作用などを示すもの
の、実際に皮膚に適用した場合、充分な色素沈着の消失
もしくは淡色化などの効果は得られていない。2. Description of the Related Art Conventionally, as a whitening cosmetic composition, a composition containing vitamin C and a derivative thereof, or a tyrosinase activity inhibitor such as a reducing agent or a placenta extract is known. However, these conventional whitening cosmetics are based on cultured cells.
In vitro experiments show an inhibitory effect on melanin production, but when actually applied to the skin, sufficient effects such as disappearance of pigmentation or lightening have not been obtained.
本発明は実際に皮膚に適用した場合、副作用がなく優
れた美白効果を奏しうる化粧料を提供することを目的と
する。An object of the present invention is to provide a cosmetic that can exhibit an excellent whitening effect without side effects when actually applied to the skin.
課題を解決するための手段 本発明者らは、前記目的を達成すべく鋭意研究を重ね
た結果、特定の脂肪酸またはその誘導体にさらに各種の
成分を組み合わせることにより皮膚の色素沈着の消失、
もしくは淡色化に優れた相乗的な効果があらわれること
を見いだし、本発明を完成するに至った。Means for Solving the Problems The present inventors have conducted intensive studies to achieve the above object, and as a result, disappearance of skin pigmentation by further combining various components with a specific fatty acid or a derivative thereof,
Alternatively, they have found that a synergistic effect excellent in lightening is obtained, and have completed the present invention.
すなわち本発明は、(a)炭素数18〜22かつ分子構造
中の不飽和結合数が2以上の遊離脂肪酸、その塩、ある
いは一価または二価アルコールとのエステル、(b)胎
盤抽出物、コウジ酸及びその誘導体、グルコサミン及び
その誘導体、アゼライン酸及びその誘導体、レチノール
及びその誘導体、ピリドキシン及びその誘導体、トラネ
キサム酸及びその誘導体、アルブチン、感光素、イオ
ウ、コンドロイチン硫酸ナトリウム、4−ヒドロキシケ
イ皮酸、並びにニンジンエキスからなる群より選ばれた
1種または2種以上の成分を配合したことを特徴とする
美白化粧料を提供するものである。That is, the present invention provides (a) a free fatty acid having 18 to 22 carbon atoms and an unsaturated bond number in a molecular structure of 2 or more, a salt thereof, or an ester with a monohydric or dihydric alcohol, (b) a placenta extract, Kojic acid and its derivatives, glucosamine and its derivatives, azelaic acid and its derivatives, retinol and its derivatives, pyridoxine and its derivatives, tranexamic acid and its derivatives, arbutin, photosensitizer, sulfur, sodium chondroitin sulfate, 4-hydroxycinnamic acid And at least one component selected from the group consisting of carrot extract.
本発明組成物に配合されるリノール酸、γ−リノレン
酸など炭素数18〜22を有し、かつ分子構造中の不飽和結
合数が2以上の脂肪酸は、植物油脂および動物油脂に含
まれている。しかし、これら脂肪酸は遊離の状態で存在
することは少なく、そのほとんどはトリグリセリドの状
態で存在する。このようなトリグリセリドは、遊離の脂
肪酸もしくはそのアルキルエステルのごとく動物試験等
において優れた色素沈着淡色化作用は認められない。ま
た、パルミチン酸、ステアリン酸などの飽和脂肪酸にあ
っても同様に色素沈着抑制効果は認められず、場合によ
っては逆にメラニン産生を亢進する。かかる飽和脂肪酸
は、植物油脂および動物油脂に多量にふくまれているた
め、本発明化粧料におけるリノール酸などの配合にあた
っては精製したものを用いることが好ましい。Fatty acids having 18 to 22 carbon atoms, such as linoleic acid and γ-linolenic acid, which are blended in the composition of the present invention, and having an unsaturated bond number of 2 or more in the molecular structure are contained in vegetable oils and fats. I have. However, these fatty acids rarely exist in a free state, and most of them exist in a triglyceride state. Such a triglyceride does not exhibit an excellent pigmentation and lightening effect in animal tests and the like, as in the case of a free fatty acid or an alkyl ester thereof. Similarly, the effect of inhibiting the pigmentation is not observed even with saturated fatty acids such as palmitic acid and stearic acid, and in some cases, the production of melanin is enhanced. Since such saturated fatty acids are contained in a large amount in vegetable oils and fats and oils, it is preferable to use purified fatty acids when blending linoleic acid in the cosmetic of the present invention.
本発明の美白化粧料に配合される炭素数18〜22かつ分
子構造中の不飽和結合数が2以上の遊離脂肪酸の代表的
なものとしては、リノール酸、リノエライジン酸、α−
リノレン酸、γ−リノレン酸、ジホモ−γ−リノレン
酸、アラキドン酸、エイコサペンタエン酸などが挙げら
れ、これらの1種または2種以上が用いられる。Representative examples of the free fatty acid having 18 to 22 carbon atoms and having 2 or more unsaturated bonds in the molecular structure to be incorporated in the whitening cosmetic composition of the present invention include linoleic acid, linoleic acid, α-
Examples thereof include linolenic acid, γ-linolenic acid, dihomo-γ-linolenic acid, arachidonic acid, and eicosapentaenoic acid. One or more of these are used.
また、これら遊離脂肪酸の塩としては、ナトリウム
塩、カリウム塩などの金属塩、アルギニン塩、リジン塩
などのアミノ酸塩、トリエタノールアミン塩、モノエタ
ノールアミン塩等のアミン塩などが挙げられる。Examples of the salts of these free fatty acids include metal salts such as sodium salt and potassium salt, amino acid salts such as arginine salt and lysine salt, and amine salts such as triethanolamine salt and monoethanolamine salt.
さらに、前記遊離脂肪酸のアルキルエステルとして
は、メタノール、エタノール、イソプロピルアルコール
などの一価アルコールとのエステル、エチレングリコー
ル、プロピレングリコール、1,3−ブチレングリコール
などの二価のアルコールとのエステルなどが挙げられ
る。Further, examples of the alkyl ester of the free fatty acid include an ester with a monohydric alcohol such as methanol, ethanol and isopropyl alcohol, and an ester with a dihydric alcohol such as ethylene glycol, propylene glycol and 1,3-butylene glycol. Can be
これら遊離脂肪酸、塩、またはエステルの化粧料中に
おける配合量は、0.1〜10重量%であるのが好ましい。
かかる配合量が、0.1重量%未満であると、色素沈着の
淡色化効果がなく、一方、10重量%を越えると、皮膚に
対して刺激性を示すようになる。The amount of these free fatty acids, salts or esters in cosmetics is preferably 0.1 to 10% by weight.
When the amount is less than 0.1% by weight, there is no lightening effect of pigmentation, and when the amount exceeds 10% by weight, the skin becomes irritating.
一方、前記脂肪酸等と共に本発明組成物に配合される
成分は、あるいはエステル、胎盤抽出物、コウシ酸及び
その塩あるいはエステル、グルコサミン及びその塩ある
いはエステル、アゼライン酸及びその塩あるいはエステ
ル、レチノール及びそのエステル、ピリドキシン及びそ
の塩あるいはエステル、トラネキサム酸及びその塩ある
いはエステル、アルブチン、感光素、イオウ、コンドロ
イチン硫酸ナトリウム、4−ヒドロキシケイ皮酸、並び
にニンジンエキスである。これらの1種または2種以上
が配合される。これら成分の化粧料組成物中における配
合量は0.1〜10重量%であるのが好ましい。かかる配合
量が0.1重量%未満であると、色素沈着の淡色化効果が
なく、一方、10重量%を越えると刺激性が強く、使用上
好ましくない。On the other hand, the components to be added to the composition of the present invention together with the fatty acids and the like, or esters, placenta extract, succinic acid and its salts or esters, glucosamine and its salts or esters, azelaic acid and its salts or esters, retinol and its Esters, pyridoxine and salts or esters thereof, tranexamic acid and salts or esters thereof, arbutin, photosensitizer, sulfur, chondroitin sulfate, 4-hydroxycinnamic acid, and carrot extract. One or more of these are blended. The content of these components in the cosmetic composition is preferably 0.1 to 10% by weight. If the amount is less than 0.1% by weight, there is no lightening effect of pigmentation, while if it exceeds 10% by weight, irritation is strong, which is not preferable for use.
これらの活性成分と前記脂肪酸類との併用により皮膚
に対し相乗的な美白効果を示すことについては従来知ら
れていない。It has not been known that a combination of these active ingredients and the above-mentioned fatty acids exhibits a synergistic whitening effect on the skin.
つぎに各種活性成分についてその色素沈着の消失もし
くは淡色化の作用を評価した結果を示す。Next, the results of evaluating the effect of various active ingredients on the disappearance of pigmentation or lightening are shown.
試験方法: English系茶色モルモットの背部を剃毛して紫外線(U
VB強度:1J/cm2)を照射し、1週間後に色素沈着を得
た。つぎに、この部位にリノール酸をはじめとする脂肪
酸、あるいは他の成分をエタノールに溶解した検体を4
週間累積塗布した。色素沈着の淡色化を評価する方法と
して、検体を塗布していない部位(無塗布)の色素沈着
度を0とし、その淡色化の度合いにより、以下に示す判
定基準に従い、色素沈着度を肉眼判定した。Test method: Shaving the back of English brown guinea pig,
VB intensity: 1 J / cm 2 ), and pigmentation was obtained one week later. Next, a sample obtained by dissolving fatty acids such as linoleic acid or other components in ethanol was added to this site.
It was applied cumulatively for a week. As a method for evaluating the lightening of pigmentation, the degree of pigmentation of a part to which a sample is not applied (uncoated) is set to 0, and the degree of pigmentation is visually determined according to the following criterion based on the degree of lightening. did.
判定基準: 0 色素沈着の淡色化が認められない −1 わずかに色素沈着の淡色化が認められる −2 中等度の色素沈着の淡色化が認められる −3 顕著な色素沈着の淡色化が認められる 結果を次の第1表に示す。Criteria: 0 No lightening of pigmentation is observed -1 Slight fading of pigmentation is observed -2 Lightening of moderate pigmentation is observed -3 Remarkable lightening of pigmentation is observed The results are shown in Table 1 below.
第1表より明らかなごとく、アスコルビン酸などの活
性成分単独では色素沈着の淡色化は認められず、また炭
素数18〜22かつ分子構造中の不飽和結合数が2以上の遊
離脂肪酸、その塩あるいはアルキルエステルを単独で配
合した場合も、色素沈着の淡色化はわずかである。これ
らに対して、前記脂肪酸、その塩あるいはアステルとア
スコルビン酸などの成分を併用した場合は、顕著な色素
沈着の淡色化が認められる。 As is clear from Table 1, the active ingredient such as ascorbic acid alone did not show any fading of pigmentation and free fatty acids having 18 to 22 carbon atoms and two or more unsaturated bonds in the molecular structure, and salts thereof. Alternatively, when the alkyl ester is used alone, the coloration of pigmentation is slightly reduced. On the other hand, when the above fatty acids, salts thereof or components such as astell and ascorbic acid are used in combination, remarkable lightening of pigmentation is observed.
本発明の美白化粧料は、公知の方法により、化粧水、
化粧用油、クリーム、乳液、パック、パウダーなどの形
態に製造される。The whitening cosmetic of the present invention, by a known method, lotion,
It is manufactured in the form of cosmetic oils, creams, emulsions, packs, powders and the like.
さらに本発明の化粧料には、その種類に応じ性能を損
なわない範囲において、適宜公知の成分を配合すること
ができる。Further, the cosmetic of the present invention may be appropriately blended with known components within a range that does not impair the performance according to the type.
なお、従来から使用されている紫外線吸収剤、紫外線
散乱剤、抗炎症剤、抗酸化剤などを配合しても良い。In addition, you may mix the conventionally used ultraviolet absorber, ultraviolet scattering agent, anti-inflammatory agent, antioxidant, etc.
実施例 つぎに本発明を実施例によりさらに具体的に説明す
る。EXAMPLES Next, the present invention will be described more specifically with reference to examples.
実施例1(化粧水) 精製水にグリセリン、クエン酸、クエン酸ナトリウ
ム、水溶性プラセンタエキスを溶解する。別個にエタノ
ールにアスコルビン酸リン酸マグネシウム塩、リノール
酸、α−リノレン酸、ポリオキシエチレン硬化ヒマシ油
(60E.O.)、メチルパラベン、香料を溶解し、前記の精
製水溶液に加えて可溶化し、ろ過して化粧水を得た。Example 1 (Lotion) Dissolve glycerin, citric acid, sodium citrate, and water-soluble placenta extract in purified water. Separately, magnesium ascorbic acid phosphate, linoleic acid, α-linolenic acid, polyoxyethylene hydrogenated castor oil (60E.O.), methylparaben, and fragrance are dissolved in ethanol and added to the purified aqueous solution to solubilize. Filtration gave a lotion.
実施例2(化粧用油) スクワランに他の成分を均一に溶解して化粧用油を得
た。Example 2 (cosmetic oil) Other ingredients were uniformly dissolved in squalane to obtain a cosmetic oil.
実施例3(クリーム) 成分(A)を加熱溶解し、80℃に保持する。別に香料
を除く成分(B)を加熱溶解して80℃に保ち、これに前
記成分(A)を撹拌しながら加え、充分混合する。さら
に撹拌しながら冷却を行い、香料を加え、さらに冷却し
てクリームを得た。Example 3 (cream) The component (A) is dissolved by heating and kept at 80 ° C. Separately, the component (B) excluding the fragrance is dissolved by heating and kept at 80 ° C., and the component (A) is added thereto with stirring and mixed well. Cooling was further performed with stirring, a flavor was added, and further cooling was performed to obtain a cream.
実施例4(乳液) 成分(A)を80℃にて加熱溶解し、別に加温(80℃)
溶解した香料を除く成分(B)に撹拌しながら加え、充
分混合する。ついで、撹拌しながら冷却を行い、香料を
加え、さらに冷却して乳液を得た。Example 4 (Emulsion) Ingredient (A) is heated and melted at 80 ° C and heated separately (80 ° C)
Add to the component (B) excluding the dissolved perfume with stirring and mix well. Then, the mixture was cooled with stirring, a fragrance was added, and the mixture was further cooled to obtain an emulsion.
実施例5(パック) コンドロイチン硫酸ナトリウム、α−リノレン酸、香
料およびエタノールを均一に溶解する。これを酢酸ビニ
ル・スチレン共重合体、ポリビニルアルコール、ソルビ
ット、酸化チタンおよびカオリンを均一に混和したもの
に加える。これに、さらに水溶性プラセンタエキス、パ
ラオキシ安息香酸エチルを精製水に均一に分解した溶液
を加え、均一に混和しパックを得た。Example 5 (pack) Dissolve sodium chondroitin sulfate, α-linolenic acid, flavor and ethanol uniformly. This is added to a homogeneous mixture of vinyl acetate / styrene copolymer, polyvinyl alcohol, sorbite, titanium oxide and kaolin. Further, a solution obtained by uniformly decomposing a water-soluble placenta extract and ethyl paraoxybenzoate in purified water was added thereto, and the mixture was uniformly mixed to obtain a pack.
実施例6(パウダー) トラネキサム酸、イオウ、リノエライジン酸およびス
テアリン酸デカグリセリルを加熱溶解し、70℃に保持
し、これをデキストリンおよびタルクの混合物に撹拌し
ながら徐々に加えてパウダーを得た。Example 6 (powder) Tranexamic acid, sulfur, linoleic acid and decaglyceryl stearate were dissolved by heating and maintained at 70 ° C., and this was gradually added to a mixture of dextrin and talc with stirring to obtain a powder.
発明の効果 本発明化粧料は、皮膚に適用することにより、紫外線
による皮膚の黒化あるいは色素沈着を消失、淡色化もし
くは予防し優れた美白効果を発揮する。Effect of the Invention The cosmetic of the present invention, when applied to the skin, eliminates, darkens or prevents blackening or pigmentation of the skin due to ultraviolet rays, and exhibits an excellent whitening effect.
Claims (1)
和結合数が2以上の遊離脂肪酸、その塩、あるいは一価
または二価アルコールとのエステルと、 (b)胎盤抽出物、コウジ酸及びその誘導体、グルコサ
ミン及びその誘導体、アゼライン酸及びその誘導体、レ
チノール及びその誘導体、ピリドキシン及びその誘導
体、トラネキサム酸及びその誘導体、アルブチン、感光
素、イオウ、コンドロイチン硫酸ナトリウム、4−ヒド
ロキシケイ皮酸、並びにニンジンエキスからなる群より
選ばれた1種または2種以上の成分 とを配合したことを特徴とする美白化粧料。(1) a free fatty acid having 18 to 22 carbon atoms and having two or more unsaturated bonds in a molecular structure, a salt thereof, or an ester with a monohydric or dihydric alcohol, and (b) a placenta extract. , Kojic acid and its derivatives, glucosamine and its derivatives, azelaic acid and its derivatives, retinol and its derivatives, pyridoxine and its derivatives, tranexamic acid and its derivatives, arbutin, photosensitizer, sulfur, sodium chondroitin sulfate, 4-hydroxycinnamic A whitening cosmetic comprising a mixture of one or more components selected from the group consisting of an acid and a carrot extract.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63011585A JP2614474B2 (en) | 1988-01-20 | 1988-01-20 | Whitening cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63011585A JP2614474B2 (en) | 1988-01-20 | 1988-01-20 | Whitening cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH01186811A JPH01186811A (en) | 1989-07-26 |
JP2614474B2 true JP2614474B2 (en) | 1997-05-28 |
Family
ID=11781982
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63011585A Expired - Lifetime JP2614474B2 (en) | 1988-01-20 | 1988-01-20 | Whitening cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2614474B2 (en) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2780989B2 (en) * | 1989-01-28 | 1998-07-30 | 三省製薬株式会社 | External preparation |
JP2593714B2 (en) * | 1989-09-20 | 1997-03-26 | 株式会社 林原生物化学研究所 | Whitening agent |
EP0570230B1 (en) * | 1992-05-15 | 1998-09-30 | Shiseido Company Limited | External preparation for skin |
US5798109A (en) * | 1992-07-13 | 1998-08-25 | Shiseido Company, Ltd. | External skin treatment composition |
US5962000A (en) * | 1992-07-13 | 1999-10-05 | Shiseido Company, Ltd. | External skin treatment composition |
JPH0632722A (en) * | 1992-07-13 | 1994-02-08 | Shiseido Co Ltd | External preparation for skin |
ES2191664T5 (en) * | 1992-07-13 | 2008-02-16 | Shiseido Company, Ltd. | COMPOSITION FOR DERMATOLOGICAL PREPARATION. |
ATE365530T1 (en) * | 1992-07-13 | 2007-07-15 | Shiseido Co Ltd | STABILIZED SKIN CARE PRODUCT CONTAINING RETINOL FOR EXTERNAL USE |
US5686086A (en) * | 1992-07-13 | 1997-11-11 | Shiseido Co., Ltd. | External skin treatment composition |
GB9223235D0 (en) * | 1992-11-05 | 1992-12-16 | Unilever Plc | Cosmetic composition |
KR960016127B1 (en) * | 1994-02-01 | 1996-12-04 | 주식회사 태평양 | Kojic acid derivatives |
JP3696271B2 (en) * | 1994-09-22 | 2005-09-14 | 花王株式会社 | Whitening cosmetics |
FR2732215B1 (en) * | 1995-03-28 | 1997-04-30 | Sederma Sa | NEW DEPIGMENTING COSMETIC COMPOSITIONS |
JP3687277B2 (en) * | 1997-06-10 | 2005-08-24 | サンスター株式会社 | Whitening cosmetics |
FR2772610B1 (en) * | 1997-12-19 | 2006-06-02 | Oreal | USE OF CINNAMIC ACID OR AT LEAST ONE OF ITS DERIVATIVES IN A COSMETIC COMPOSITION |
FR2772612B1 (en) * | 1997-12-19 | 2003-01-10 | Oreal | USE OF CINNAMIC ACID OR DERIVATIVES THEREOF IN A FIRMING COSMETIC COMPOSITION |
FR2778560B1 (en) | 1998-05-12 | 2001-06-01 | Oreal | USE OF CINNAMIC ACID OR AT LEAST ONE OF ITS DERIVATIVES IN A COMPOSITION FOR PROMOTING DEQUAMATION OF THE SKIN, AND COMPOSITION COMPRISING SAME |
EP1210077A4 (en) * | 1999-06-15 | 2002-12-18 | Benjamin D Gordon | Compositions and systems for the treatment of hyperpigmentation |
GB9918028D0 (en) * | 1999-07-30 | 1999-09-29 | Unilever Plc | Skin care composition |
DE10019255A1 (en) * | 2000-04-18 | 2001-10-31 | Henkel Kgaa | Glycoside esters and their production and use in cosmetics, pharmaceuticals and food or feed |
JP2002097113A (en) * | 2000-09-22 | 2002-04-02 | Japan Natural Laboratory Co Ltd | Pack material |
JP4524935B2 (en) * | 2001-02-16 | 2010-08-18 | 日油株式会社 | Whitening cosmetics |
US7189759B2 (en) | 2001-05-23 | 2007-03-13 | Medicis Pharmaceutical Corporation | Compositions for the treatment of pigmentation disorders and methods for their manufacture |
JP3747192B2 (en) * | 2002-08-30 | 2006-02-22 | 株式会社コーセー | Topical skin preparation |
JP4653513B2 (en) * | 2004-02-25 | 2011-03-16 | 株式会社コーセー | Skin preparation |
FR2870124B1 (en) * | 2004-05-14 | 2006-07-07 | Galderma Res & Dev | DERMATOLOGICAL COMPOSITION FOR THE TREATMENT OF PIGMENT DISORDERS OF THE SKIN |
EP1888015A1 (en) * | 2005-05-03 | 2008-02-20 | Unilever Plc | Skin lightening composition comprising a conjugated linoleic acid and niacinamide |
JP5399701B2 (en) * | 2006-03-14 | 2014-01-29 | 株式会社コーセー | Whitening skin external preparation and skin whitening method |
JP5671211B2 (en) * | 2008-12-22 | 2015-02-18 | ポーラ化成工業株式会社 | External preparation for skin containing hydroxycarboxylic acid derivative |
FR2949065B1 (en) * | 2009-08-17 | 2011-10-21 | Natura Cosmeticos Sa | SKIN LIGHTENING COMPLEX, USE OF SAID COMPLEX, COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING SAID COMPLEX AND METHOD FOR APPLICATION THEREOF |
JP7139034B2 (en) * | 2018-02-28 | 2022-09-20 | 株式会社コーセー | Cosmetics and external skin preparations |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6140210A (en) * | 1984-06-01 | 1986-02-26 | ロシデイ・イスマイル | Skin treating and protecting drug |
-
1988
- 1988-01-20 JP JP63011585A patent/JP2614474B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH01186811A (en) | 1989-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2614474B2 (en) | Whitening cosmetics | |
JP2608745B2 (en) | Whitening cosmetics | |
WO1998056338A1 (en) | Skin-lightening cosmetic | |
JPS59500129A (en) | Sebum-inhibiting cosmetic agent containing long-chain alkanol and antioxidant | |
JPH0567125B2 (en) | ||
JPH05186324A (en) | Beautifying cosmetic | |
JP2002173449A (en) | Hair-growing agent | |
JPWO2007105706A1 (en) | Whitening skin external preparation and skin whitening method | |
JP2002138014A (en) | Fine emulsion composition | |
JP6263346B2 (en) | Skin preparations and cosmetics | |
JPH0881325A (en) | Cosmetic | |
JP2881333B2 (en) | Whitening cosmetics | |
JPH0867621A (en) | Skin activator having glycosaminoglycan production-accelerating action | |
JPH0193520A (en) | Beautifying and whitening cosmetic | |
JP2608777B2 (en) | Whitening cosmetics | |
JP2665976B2 (en) | Cosmetics | |
WO2012102364A1 (en) | Composition containing polyunsaturated fatty acid | |
JP3170024B2 (en) | Whitening cosmetics | |
JPH09291021A (en) | Beautifying and whitening cosmetic | |
JP2628328B2 (en) | Whitening cosmetics | |
JP2009269851A (en) | Inhibitor of prostaglandin e2 production and its utilization | |
JPH05201847A (en) | Skin-beautifying cosmetic | |
JP3258801B2 (en) | Skin metabolism promoter | |
JPH05194176A (en) | Skin-beautifying cosmetic | |
JP2644353B2 (en) | Whitening cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |